Advancing senescence translation through the Senotherapeutics Biomarker Consortium

Nat Aging. 2026 Apr;6(4):739-741. doi: 10.1038/s43587-026-01097-z.

Authors

Marco Quarta¹, Nicola Neretti², Heinrich Jasper³, Marco Demaria⁴

Affiliations

¹ Rubedo Life Sciences, Inc., Sunnyvale, CA, USA. marcoquarta@rubedolife.com.
² Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, USA.
³ Genentech, Inc., South San Francisco, CA, USA.
⁴ European Research Institute for the Biology of Ageing (ERIBA, University Medical Center Groningen (UMCG), University of Groningen (RUG), Groningen, Netherlands. m.demaria@umcg.nl.

PMID: 41776308
DOI: 10.1038/s43587-026-01097-z

No abstract available

Publication types

Letter

Grants and funding

UH3CA268202/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)